Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,785.89
(
0.13%
)
News Focus
News Focus
Post# of 704049
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

madrose1

Send PM Follow Ignore
Followers 282
Posts 47139
Boards Moderated 10
Alias Born 04/07/2001

madrose1

Member Level

Re: Zeev Hed post# 459344

Tuesday, 02/28/2006 8:13:09 AM

Tuesday, February 28, 2006 8:13:09 AM

Post# of 704049
VPHM ViroPharma beats, excluding tax benefit, guides FY06 in line (21.30 )

Reports Q4 (Dec) earnings of $0.41 per share, excluding $0.76 tax benefit, $0.14 better than the Reuters Estimates consensus of $0.27; revenues rose 118.7% year/year to $40.5 mln vs the $36.8 mln consensus. Co issues in-line guidance for FY06, sees revs of $160-170 mln vs. $167.27 mln consensus.

Know how to make God laugh?
Tell Her your plans ....

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today